SYDNEY, SEPT 6 - A new meta-analysis published in Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
On August 25 2019, the 5th ‘Salt Substitute and Stroke Study (SSaSS)’ annual meeting was held in Dalian. Over 60 investigators participated in the meeting to review progress of the trial and share experiences and insights.
It turns out that British food isn’t that terrible, after all. A global survey has found that when it comes to having the healthiest packaged foods and drinks, the UK tops the charts, with the USA in 2nd place and Australia coming in at 3rd.
You may have heard of evidence gap maps – they have been used in health, social and environmental research for a while now. But, let’s be honest, is it possible some of us glaze over when hearing the words ‘evidence’, ‘gap’ and ‘map’ linked together?
A new study, published in The Lancet Neurology, has revealed an optimal approach to lowering elevated blood pressure (BP) for treating patients with acute stroke due to spontaneous bleeding in the brain (intracerebral haemorrhage or ICH), the most serious type of stroke.
Wang Du is a diabetes Research Fellow at the George Institute, China. She is also the Assistant to the Chairman of the International Diabetes Federation (IDF), Western Pacific Region. Let us hear more about her story.
Researchers in China were awarded joint funding from four major United Kingdom agencies, the Medical Research Council (MRC), National Institute for Health Research (NIHR), Department of International Development (DIFID) and Wellcome Trust, for a clinical trial to improve the management of acute intracerebral haemorrhage in low and middle-income countries.